Conference 2015

Meningitis and Septicaemia in Children and Adults 2015

Wednesday 4 and Thursday 5 November 2015

Royal Society of Medicine, 1 Wimpole Street, London W1G 0AE London UK

Our tenth conference will bring together internationally renowned experts from a range of specialties in the UK and abroad to address the most important issues of the day, including burden of illness, recognition and treatment, vaccine development, vaccine implementation and public health policy.

Attracting delegates from around the world, this conference is a key event in the calendar for some of the foremost scientists and clinicians and provides an excellent opportunity to discuss the latest developments within the field.

Confirmed programme:

Day 1 - Wednesday 4 November

8:00-9:10 Registration and Coffee
9:10 Welcome Chris Head, CEO, Meningitis Research Foundation, UK
9:20-9:40 Patient experience of meningococcal disease TBC, Member of Meningitis Research Foundation

Current issues in clinical management– Chair: Dr Simon Nadel

9:40 - 10:10 Revision of the Surviving Sepsis Guidelines: an appraisal of the evidence base Prof Richard Beale, Intensive Care, Guy’s and St Thomas’ Hospital, London
10:10 - 10:40 Adult bacterial meningitis / meningococcal sepsis guideline Dr Fiona McGill University of Liverpool.

10:40-11:10 COFFEE, EXHIBITION AND POSTERS

Group B Streptococcal and neonatal infection – Chair: Prof Robert Heyderman

11:10-11:40
Clinical care of neonatal meningitis in the UK - Dr Ifeanyichukwu Okike, Derby Children’s Hospital
11:40-12:10 Aetiology, presentation and outcome of neonatal meningitis & sepsis including GBS in Africa– Dr Queen Dube, Queen Elizabeth Central Hospital, Malawi
12:10-12:40 Prospects for prevention of GBS – Dr Margarit Y Ros Novartis, Siena

12:40-13:40 LUNCH, EXHIBITION AND POSTERS

Meningococcal carriage – Chair: Dr Caroline Trotter
13:40-14:10
Meningococcal carriage in the African meningitis belt and the impact of MenAfriVac: an overview of the MenAfriCar project– Prof Sir Brian Greenwood, LSHTM
14:10-14:40 UK meningococcal ACWY and B carriage studies and realisation of genome sequencing – Prof Martin Maiden, University of Oxford
14:40-15:20 Debate: Adolescent immunisation against meningococcal B disease should be introduced now – Prof Robert Read, University of Southampton vs Prof Adam Finn, University of Bristol

15:20-15:50 TEA, EXHIBITION AND POSTERS

Preventing pneumococcal disease – Chair: Prof Adam Finn

15:50 -16:20
Impact of 13V pneumococcal vaccine on invasive pneumococcal disease and meningitis in the UK Prof Elizabeth Miller, Public Health England, London
16:20 -16:50 Prospects for future prevention of pneumococcal infection Dr Mark Alderson, PATH

Evening wine reception for all delegates and participants

Day 2 – Thursday 5 November

8:00 Registration and Coffee

Controlling meningococcal disease around the globe – Chair: TBC
Emergence of a virulent new meningococcal W sequence type 11 in South America and the UK

9:00-9:25 The South American experience, control measures and impact Dr Marco Safadi, Head of the Pediatric Infectious Disease Division at Sao Luiz Hospital in Sao Paulo, Brazil;
9:25-9:50 First use of genomics to inform national meningococcal immunisation policy Dr Jay Lucidarme Vaccine Evaluation Unit, PHE Manchester

9:50-10:20 Experience and impact of Bexsero in a regional programme in Quebec Prof Philippe de Wals Laval University, Quebec City


10:20-10:50 COFFEE, EXHIBITION AND POSTERS

Controlling meningococcal disease around the globe – Chair: TBC

10:50-11:15
The impact of MenAfriVac in the Meningitis Belt and prospects for meningococcal disease prevention through EPI and higher valent vaccines Dr Marie-Pierre Preziosi, Medical Officer, Initiative for Vaccine Research, Department of Immunization, Vaccines and Biologicals, World Health Organization
11:15-11:40 Current epidemiology of meningococcal disease in the Meningitis Belt and new WHO outbreak response guidelines after the Meningitis Vaccine Project Dr Olivier Ronveaux, WHO meningitis team, Geneva

11:40 -12:10 Meningococcal B outbreaks in US universities – Dr Nicole Basta, University of Minnesota

12:10 LUNCH, EXHIBITION AND POSTERS

13:10 -13:50 Poster presentations from the top 5 poster abstracts and award for the best poster (~5 minute presentations) – Chair: Prof David Lalloo

Advances from research – Chair: Prof Nigel Klein

13:50 -14:15
Host genetic control of susceptibility and outcome of meningococcal disease Prof Michael Levin Imperial College London/St Mary’s
14:15 -14:40 Vascular colonisation by meningococcal bacteria – Prof Xavier Nassif INSERM Paris
14:40-15:05 Epidemics of Non-typhoidal Salmonella Sepsis and Meningitis in Africa – Prof Robert Heyderman, University College London

15:05-15:30 COFFEE, EXHIBITION AND POSTERS

Prevention of meningococcal disease in the UK – Chair: Prof Ian Feavers

15:30-16:10 Introduction of Bexsero and MenACWY in the UK Dr Mary Ramsay, PHE, London
16:10-16:40 Plans for enhanced surveillance and evaluation of efficacy of Bexsero Prof Ray Borrow, PHE Vaccine Evaluation Unit, Manchester
16:40 – 17:10 Implementation and evaluation of new vaccination programmes in the UK – Panel discussion Q&A


Steering committee:

  • Professor Ray Borrow, Public Health England
  • Professor Ian Feavers, National Institute for Biological Standards and Control
  • Professor Adam Finn, University of Bristol
  • Professor Brian Greenwood, London School of Hygiene and Tropical Medicine
  • Professor George Griffin, St George’s University London
  • Professor Paul Heath, St George’s University London
  • Professor Rob Heyderman, University College London
  • Professor Nigel Klein, Great Ormond Street/University College London
  • Professor David Lalloo, Liverpool School of Tropical Medicine
  • Dr Simon Nadel, St Mary’s Hospital / Imperial College London
  • Dr Mary Ramsay, Public Health England
  • Professor Christoph Tang, University of Oxford
  • Dr Caroline Trotter, University of Cambridge
  • Linda Glennie, Meningitis Research Foundation
Call for poster abstracts for Meningitis and Septicaemia in Children and Adults 2015

Conference sponsorship opportunities

Delegate fees:

Standard non-commercial  rate
early booking discount before 7 September
One day - £140- Book online with your credit or debit card
Both days - £220 - Book online with your credit or debit card

Commercial  rate
One day - £260 - Book online with your credit or debit card
Both days - £350 - Book online with your credit or debit card

Discounted fees for junior trainees, nurses and post-docs
One day - £110 - Book online with your credit or debit card
Both days - £175 -Book online with your credit or debit card

If you prefer, you can use our downloadable booking form:

  • Download Conference Booking Form
  • For more information, to book over the phone or to raise a booking invoice to pay against, please email Paul George or call him on +44 (0)1454 281811

    Conference accomodation

    Subject to availability, a number of special rate rooms are available to guests at the Imperial Hotel, WC1B 5BB and the President Hotel, WC1N 1DB.

    Delegates should contact the Central Reservation Office: info@imperialhotels.com Tel: 020 7278 7871 and quote allocation held for "MERF" together with the name of the hotel they wish to book.

    • Credit/debit card details will be taken to guarantee booking
    • Cancellation to be received before 11.00am on the day prior to expected arrival
    • All 'no-shows' all late cancellations will be charged for first night 

    Meningitis and Septicaemia in Children and Adults 2015's major sponsors are:



    Novartis Vaccines' non-influenza business has now transferred to GSK

    The conference is also supported by: